Dyne Therapeutics · 12 hours ago
Director, US Data and Advanced Analytics
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Director, US Data and Advanced Analytics will build and synthesize a data ecosystem to inform decision-making related to brand and channel strategies, leveraging advanced analytical techniques and cross-functional collaboration to optimize business readiness for neuromuscular rare disease launches.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead the utilization of advanced analytical techniques (AI/ML, predictive modeling) in collaboration with IT, leveraging structured and unstructured data across market research, demand forecasting, promotional mix, ad-hoc analytics, and customer/market insights to inform US execution strategy
Deep understanding of real-world data, such as anonymized longitudinal patient claims data, lab/diagnostic testing data, EMR, to provide patient-level analytics
Proficiency with claims data sets such as Komodo, IQIVA, Definitive Healthcare
Partner with I&A lead for US market research and US forecasting
Lead market research, demand planning and forecasting for DMD and DM1 markets by end of 2026
In collaboration with IT, build a best-in-class data ecosystem to answer key business questions and create insightful visualizations, making sense of complex datasets and methodologies
Lead story development and presentation of commercial analytics to ensure stakeholder buy-in
Develop promotional marketing mix response process and omnichannel effectiveness analytics in collaboration with head of omnichannel and digital
Plan, direct, oversee and provide thought leadership for advanced analytical approaches, including artificial intelligence and machine learning
Develop high quality solutions and answers to ad-hoc business questions with commercial and senior leadership
Lead KPI workshop identification to develop KPI dashboards and commercial scorecards
Leverage large and complex data from HUB, SP’s, SIP’s, data aggregator, claims, EMR and diagnostic to build a patient finding capability
Manage vendor relationships and overall project management with external vendors, IT commercial business partner, commercial leadership, brand teams, and other commercial stakeholders across the US commercial organization
Qualification
Required
Bachelor's degree and 10+ years of relevant experience
7+ years of biotech/pharma/life sciences experience industry experience with relevant experience in commercial analytics, sales operations, predictive modeling, omnichannel analytics and patient level data analytics
Proven track record of developing and implementing AI and ML solutions
Relevant expertise using analytical tools such as excel, SAS, SQL, Snowflake, R or Python
In-depth understanding and experience using advanced analytical techniques to assess strategic business questions, resulting in value creation
Strong analytical and organizational skills experienced in managing multiple projects, analytical resources, vendors/consultants and cross-functional teams
Expertise working with patient level claims data sets and other large data sets
Ability to think strategically and anticipate future analytical trends
Excellent communication skills and problem-solving skills
Strong writing and verbal communication skills, including ability to present to senior management
Preferred
advanced quantitative analytics preferred
consulting experience preferred
Past rare disease launch experience preferred
Company
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
H1B Sponsorship
Dyne Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (7)
2023 (1)
2022 (3)
2021 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M
Recent News
2026-01-11
2026-01-07
2025-12-24
Company data provided by crunchbase